Related Experiment Video
Updated: Jun 1, 2026

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
Published on: March 22, 2016
Manufacturing of retroviruses
Pedro E Cruz1, Teresa Rodrigues, Marlene Carmo
1Animal Cell Technology Laboratory, IBET/ITQB-UNL, Oeiras, Portugal.
Abstract:
Retrovirus vectors derived from moloney murine leukemia virus (MoMLV) were the first class of viral vectors developed for gene therapy. They have been extensively used in clinical trials, particularly in ex vivo transduction of hematopoietic stem cells. Although there is a vast experience acquired with retroviruses, their manufacturing is still a difficult task due to the low cell productivities and inherent instability of the infective virus. These viral vectors are most commonly produced using stable producer cell lines in adherent monolayer culture systems. In order to obtain high transduction efficiencies and low toxicity in clinical applications, the viral preparations should be purified, concentrated, and well characterized to attain stringent quality specifications. This chapter describes currently used protocols for manufacturing retroviruses.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Size and Structure of Viral Genomes
Mechanisms of Retrovirus-induced Cancers
Inhibitors of Virion Maturation and Assembly
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
